FRIDAY, Sept. 20, 2019 -- Young and middle-aged adults with low vitamin D levels may live shorter lives, a large study suggests.
The findings come from a 20-year follow-up of more than 78,000 Austrian adults. Researchers found that those with low vitamin D levels in their blood were nearly three times more likely to die during the study period than those with adequate levels.
TUESDAY, June 18, 2019 -- Victoza (liraglutide) injection is now approved to treat type 2 diabetes in children 10 years and older, the U.S. Food and Drug Administration announced.
Approved to treat type 2 diabetes in adults in 2010, Victoza is the first noninsulin drug to be approved to treat type 2 diabetes in children since metformin in 2000. Victoza's labeling states that the injection is not a substitute for insulin and is not indicated for patients with type 1 diabetes or those with diabetic ketoacidosis. Dosage of Victoza in children should start at 0.6 mg daily for at least one week. The manufacturer's prescribing information indicates that if additional glycemic control is required, the dose should be increased to 1.2 mg daily, and then to 1.8 mg daily after at least one week of treatment with the 1.2-mg daily dose if additional control is still required.